1. Home
  2. SIG vs TVTX Comparison

SIG vs TVTX Comparison

Compare SIG & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SIG
  • TVTX
  • Stock Information
  • Founded
  • SIG 1950
  • TVTX 2008
  • Country
  • SIG Bermuda
  • TVTX United States
  • Employees
  • SIG N/A
  • TVTX N/A
  • Industry
  • SIG Consumer Specialties
  • TVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SIG Consumer Discretionary
  • TVTX Health Care
  • Exchange
  • SIG Nasdaq
  • TVTX Nasdaq
  • Market Cap
  • SIG 2.3B
  • TVTX 1.9B
  • IPO Year
  • SIG N/A
  • TVTX N/A
  • Fundamental
  • Price
  • SIG $58.85
  • TVTX $19.68
  • Analyst Decision
  • SIG Buy
  • TVTX Strong Buy
  • Analyst Count
  • SIG 4
  • TVTX 13
  • Target Price
  • SIG $74.00
  • TVTX $33.17
  • AVG Volume (30 Days)
  • SIG 1.8M
  • TVTX 1.6M
  • Earning Date
  • SIG 03-19-2025
  • TVTX 05-05-2025
  • Dividend Yield
  • SIG 2.18%
  • TVTX N/A
  • EPS Growth
  • SIG N/A
  • TVTX N/A
  • EPS
  • SIG N/A
  • TVTX N/A
  • Revenue
  • SIG $6,703,800,000.00
  • TVTX $233,175,000.00
  • Revenue This Year
  • SIG $2.08
  • TVTX $72.95
  • Revenue Next Year
  • SIG $1.23
  • TVTX $53.84
  • P/E Ratio
  • SIG N/A
  • TVTX N/A
  • Revenue Growth
  • SIG N/A
  • TVTX 60.55
  • 52 Week Low
  • SIG $45.55
  • TVTX $5.12
  • 52 Week High
  • SIG $112.06
  • TVTX $25.29
  • Technical
  • Relative Strength Index (RSI)
  • SIG 59.22
  • TVTX 45.64
  • Support Level
  • SIG $59.10
  • TVTX $20.29
  • Resistance Level
  • SIG $61.80
  • TVTX $20.98
  • Average True Range (ATR)
  • SIG 2.39
  • TVTX 0.90
  • MACD
  • SIG 1.48
  • TVTX 0.07
  • Stochastic Oscillator
  • SIG 81.85
  • TVTX 54.12

About SIG Signet Jewelers Limited

Signet Jewelers Ltd is a retailer of diamond jewelry. Its merchandise mix includes bridal, fashion, watches and others. The bridal category includes engagement, wedding and anniversary purchases. Its segments are the North America segment, the International segment, and the Other segment. The North America segment contributes to the majority of the revenue. The North America segment generates revenue from Mall and Off-mall & Outlet.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Share on Social Networks: